HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Three cardiovirus Leader proteins equivalently inhibit four different nucleocytoplasmic trafficking pathways.

Abstract
Cardiovirus infections inhibit nucleocytoplasmic trafficking by Leader protein-induced phosphorylation of Phe/Gly-containing nucleoporins (Nups). Recombinant Leader from encephalomyocarditis virus, Theiler׳s murine encephalomyelitis virus and Saffold virus target the same subset of Nups, including Nup62 and Nup98, but not Nup50. Reporter cell lines with fluorescence mCherry markers for M9, RS and classical SV40 import pathways, as well as the Crm1-mediated export pathway, all responded to transfection with the full panel of Leader proteins, showing consequent cessation of path-specific active import/export. For this to happen, the Nups had to be presented in the context of intact nuclear pores and exposed to cytoplasmic extracts. The Leader phosphorylation cascade was not effective against recombinant Nup proteins. The findings support a model of Leader-dependent Nup phosphorylation with the purpose of disrupting Nup-transportin interactions.
AuthorsJessica J Ciomperlik, Holly A Basta, Ann C Palmenberg
JournalVirology (Virology) Vol. 484 Pg. 194-202 (Oct 2015) ISSN: 1096-0341 [Electronic] United States
PMID26115166 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Nuclear Pore Complex Proteins
  • Viral Proteins
Topics
  • Active Transport, Cell Nucleus
  • Animals
  • Encephalomyocarditis virus (physiology)
  • HeLa Cells
  • Host-Pathogen Interactions
  • Humans
  • Mice
  • Nuclear Pore Complex Proteins (antagonists & inhibitors, metabolism)
  • Protein Processing, Post-Translational
  • Theilovirus (physiology)
  • Viral Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: